Search for a command to run...
Promoters and Public shareholders in Bal Pharma Ltd. have both reduced their stakes, with a YoY decline of 0.39% and 0.62% respectively, while Institutions remained unchanged, indicating a lack of confidence.
In contrast, sector averages show no changes among Promoters, Institutions, or the Public, suggesting that Bal Pharma Ltd. is underperforming relative to its peers.
The overall decline in both Promoter and Public holdings signals a bearish sentiment towards Bal Pharma, making it a potential candidate for cautious investment.
| Category | Trend | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
1Promoter29 | 51.25% | 51.25% | 51.25% | 50.86% | 50.86% | 50.86% | 50.86% | 50.86% | |
2Institution4 | - | - | 10.48% | - | - | - | - | - | |
3Public17 | 15.19% | 15.31% | 4.8% | 14.69% | 14.59% | 14.69% | 14.67% | 14.62% |